Results of General Meeting and Board Changes

AI SummaryClose X

Cellbxhealth plc announced that all resolutions were passed at its General Meeting, paving the way for the admission of 816,760,990 New Ordinary Shares to AIM, with the first admission expected on December 16, 2025, and the second on December 18, 2025, bringing the total voting rights to 1,139,402,658. The company also confirmed the permanent appointment of Peter Collins as Chief Executive Officer, transitioning from his interim role, and anticipates four board appointments in January 2026, subject to due diligence.

Disclaimer*

UK 100

Latest directors dealings